July 23, 2025
3 min watch
LOS ANGELES — On this Healio Video Perspective, Mark Papini of Sight Sciences overviews the Omni Edge Surgical System for glaucoma, which debuted on the ASCRS assembly.
In accordance with Papini, the Omni Edge’s TruSync know-how allows the “secure, reproducible and predictable” deployment of viscoelastic fluid into Schlemm’s canal. It has been utilized in greater than 300,000 instances and has proven constructive outcomes as each a stand-alone therapy and together with cataract surgical procedure.
The system acts as a “complete” choice that treats the three resistance factors within the outflow pathway, Papini stated.
“With TruSync know-how, we’re capable of deliver up the viscoelastic to actually attain extra surgeons by way of that rising choice for extra viscoelastic to deal with their sufferers,” Papini advised Healio. “Omni Edge represents that subsequent evolution and brings 21 µL to bear within the therapy of your glaucoma sufferers.”
Sources/Disclosures
Collapse
Healio Interviews
Disclosures:
Papini reviews being vp of worldwide advertising and marketing and business technique at Sight Sciences.
